DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”
In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs
DCT Board Approves Concepts For New RFA, New And Recompeting Contracts
Major Changes In NCI Drug screening Tumor Panels Approved
Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal
Ethics Commission Say HHS Should Test Injury Compensation
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
